At Digestive and Liver Health Specialists, our supportive healthcare team specializes in weight management
discontinue at least 2 months before planned conception) Individuals seeking cholesterol management as the sole therapeutic goal without diabetes or obesity Patients already taking another GLP-1 receptor agonist Healthcare providers should conduct comprehensive cardiovascular risk assessment and ensure patients meet appropriate criteria before prescribing semaglutide
It also plays a role in growth hormone replacement therapy, aiming to restore GH release to optimal levels
Weight loss injections primarily include glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound)
14 , 1248985 (2023) Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors
Orforglipron provides a convenient oral option with moderate but meaningful weight loss
